title: The effect of intravenous ketorolac on capsaicin-induced deep tissue hyperalgesia.
abstract: Preclinical and clinical studies have emphasized that persistent small afferent input will induce a state of central facilitation that can be attenuated by systemically administered nonsteroidal antiinflammatory drugs. However, these studies have been performed using cutaneous models of hyperalgesia. In this study we evaluated the effects of IV ketorolac on an experimental model of deep tissue hyperalgesia using IM capsaicin. We used a double-blind, placebo-controlled, crossover design. Ten subjects received 60 mg of ketorolac or placebo in 2 sessions separated by 1 wk. Capsaicin (100 microg in 10 microL) was then injected into the flexor carpi ulnaris muscle of the left forearm. After injection, spontaneous pain scores, pressure pain scores, gripping pain, pain distribution, and pain quality were recorded at 0, 5, 10, 15, 20, and 25 min. Cutaneous allodynia and dysesthesia were then mapped and thermal and mechanical thresholds were measured. The IM injection of capsaicin resulted in a reliable report of pain, hyperalgesia, and referred pain. Ketorolac had no effect on spontaneous pain, elicited pain, pain distribution, or secondary hyperalgesia induced by capsaicin. The findings of this study support the feasibility of further pharmacological studies using the IM capsaicin pain model.
authors.affiliation: Department of Anesthesiology, University of California San Diego, San Diego, California, USA.
authors.forename: Keeran
authors.initials: K
authors.lastname: Kumar
authors.forename: Greg R
authors.initials: GR
authors.lastname: Polston
authors.forename: Mark S
authors.initials: MS
authors.lastname: Wallace
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002211:Capsaicin / Q000494:pharmacology*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006930:Hyperalgesia / Q000139:chemically induced*; D007262:Infusions, Intravenous / Q000379:methods*; D020910:Ketorolac / Q000494:pharmacology*; D008297:Male; D010146:Pain / Q000188:drug therapy; D010147:Pain Measurement; D017288:Pain Threshold / Q000187:drug effects*; D010919:Placebos
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010919:Placebos; D002211:Capsaicin; D020910:Ketorolac